(64) demonstrated that KRAS-mutant NSCLC relies on GATA2, and the deletion of GATA2 reduces the activity of KRAS-mutant NSCLC cells without affecting the wild-type cells. Here, GATA2 is linked to non-small cell lung carcinoma.